Kristensen Jens D, Post Claes, Gordh Torsten, Svensson Björn A
Department of Anaesthesiology, University Hospital, S-751 85 UppsalaSweden Department of Pharmacology, Uppsala University, UppsalaSweden Department of Anatomy, Uppsala University, UppsalaSweden.
Pain. 1993 Sep;54(3):309-316. doi: 10.1016/0304-3959(93)90030-S.
Drugs that antagonize the action of excitatory amino acids on the NMDA receptor in the spinal cord are of interest in pain treatment. Before such drugs can be applied clinically, their potential toxicity should be studied. This study was performed in rats in order to reveal possible neurotoxicologic side effects following chronic intrathecal (i.t.) application of two NMDA receptor antagonists: 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) and kynurenic acid (KYN). Rats equipped with i.t. catheters were injected twice a day for 2 weeks with saline, 2 nmol (0.5 micrograms) CPP or 210 nmol (40 micrograms) KYN, where the doses of CPP and KYN were chosen on the basis of similar analgesic effects after one administration. Antinociception was tested daily using the tail-flick and hot-plate tests. The antinociceptive effect was similar in CPP- and KYN-treated rats on days 1 and 2. The effect of CPP decreased during the following days, whereas that of KYN persisted for the 12-day testing period. The spinal cord was then removed and prepared for light and electron microscopic examination, and a morphometric method using an unbiased stereological estimator of cell number and cell volume was applied as a sensitive variable of spinal cord neurotoxicity. Morphologic and ultrastructural analyses of the spinal cord segment adjacent to the tip of the catheter showed normal appearance with no differences between the groups. Furthermore, no differences in cell number or cell volume in the dorsal horn were found between the groups. In conclusion, chronic i.t. administration of pharmacologically active doses of CPP and KYN in rats did not produce neurotoxic effects in the spinal cord.(ABSTRACT TRUNCATED AT 250 WORDS)
能够拮抗兴奋性氨基酸对脊髓中N-甲基-D-天冬氨酸(NMDA)受体作用的药物在疼痛治疗方面具有吸引力。在这类药物能够应用于临床之前,应研究其潜在毒性。本研究在大鼠身上进行,以揭示鞘内长期注射两种NMDA受体拮抗剂——3-(2-羧基哌嗪-4-基)丙基-1-膦酸(CPP)和犬尿喹啉酸(KYN)后可能出现的神经毒理学副作用。给配备了鞘内导管的大鼠每天注射两次,持续2周,分别注射生理盐水、2 nmol(0.5微克)CPP或210 nmol(40微克)KYN,其中CPP和KYN的剂量是根据单次给药后相似的镇痛效果选定的。每天使用甩尾试验和热板试验测试抗伤害感受作用。在第1天和第2天,CPP和KYN处理组大鼠的抗伤害感受作用相似。CPP的作用在随后几天减弱,而KYN的作用在12天的测试期内持续存在。然后取出脊髓并制备用于光镜和电镜检查,应用一种使用无偏立体估计细胞数量和细胞体积的形态计量学方法作为脊髓神经毒性的敏感变量。对导管尖端相邻脊髓节段的形态学和超微结构分析显示外观正常,各组之间无差异。此外,各组之间背角的细胞数量或细胞体积也没有差异。总之,在大鼠中鞘内长期给予药理活性剂量的CPP和KYN不会在脊髓中产生神经毒性作用。(摘要截短于250字)